Sichuan Kelun-Biotech Biopharmaceutical has reported published Phase III results for trastuzumab botidotin in patients w...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial evaluating leriglitazo...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
Based at the Saw Swee Hock School of Public Health, National University of Singapore, ADVANCE-ID is Singapore’s 13...
Everest Medicines has received approval from China’s National Medical Products Administration for CARDAMYST, or et...
China Medical System Holdings has announced that its subsidiary Dermavon Holdings has received approval from China&rsquo...
DHL Group is expanding its life sciences and healthcare logistics infrastructure in Singapore through new and upgraded f...
FedEx is strengthening its healthcare and life sciences logistics network in Asia Pacific, with its Singapore Life Scien...
DHL Express Singapore has entered into a strategic partnership with Life Science Incubator to support capability buildin...
Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investig...
Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...
Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran ...
Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal stu...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasi...
Alebund Pharmaceuticals has reported progress across its renal disease portfolio, including completion of enrolment in a...
Antengene has received approval in Australia to initiate a Phase I clinical study of ATG-201, its investigational CD19/C...
Australian oncology biotechnology company Kazia Therapeutics has reported a 100% clinical benefit rate among the first s...
Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mits...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...
